Senior insider sale
Chief Development Officer at REVOLUTION MEDICINES, INC. — senior position signals high conviction
$1.34M
6.65K shares
What this filing means
SANDLER ALAN B. plans to sell 6.65K shares of REVOLUTION MEDICINES, INC. valued at approximately $1.34M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/29/2026ACC: 0001950047-26-009862
Officer· Chief Development Officer
Since Mar 2026
6.65K
Shares to sell
$1.34M
Approx. market value
6.31K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
9/29/2026
6KRestricted Stock Units
N/A
9/15/2026
309.00Total acquired6.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/29/2026 | Exercise of Stock Options Cash | 6K | — |
9/15/2026 | Restricted Stock Units N/A | 309.00 | — |
| Total | 6.31K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
341.00
Market value
$67.9K
9/16/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.31K
Market value
$1.27M
9/29/2026
Total
Units
6.65K
Value
$1.34M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 341.00 | $67.9K | — | Completed |
| Planned — Approximate Date | ||||
9/29/2026 | 6.31K | $1.27M | NASDAQ | Planned |
| Total | 6.65K | $1.34M | ||